Aevi Genomic Medicine (GNMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Operating Expenses | 10,935 | 8,480 | 10,571 | 11,686 | 11,142 |
| Operating Income | -10,935 | -8,480 | -10,571 | -11,686 | -11,142 |
| Other Income | 18 | -3 | 14 | -18 | -2 |
| Pre-tax Income | -10,917 | -8,483 | -10,557 | -11,704 | -11,144 |
| Income Tax | N/A | 0 | 13 | 3 | N/A |
| Net Income Continuous | -10,917 | -8,483 | -10,570 | -11,707 | -11,144 |
| Net Income | $-10,917 | $-8,483 | $-10,570 | $-11,707 | $-11,144 |
| EPS Basic Total Ops | -0.29 | -0.21 | -0.29 | -0.35 | -0.34 |
| EPS Basic Continuous Ops | -0.29 | -0.22 | -0.29 | -0.35 | -0.34 |
| EPS Diluted Total Ops | -0.29 | -0.21 | -0.29 | -0.35 | -0.34 |
| EPS Diluted Continuous Ops | -0.29 | -0.22 | -0.29 | -0.35 | -0.34 |
| EBITDA(a) | $-10,894 | $-8,442 | $-10,466 | $-11,619 | $-11,084 |